NexgenRx

NexgenRx EBIT

The EBIT of NexgenRx (NXG.V) as of Nov 3, 2026 is 2.23 M CAD. In the previous year, EBIT was 1.20 M CAD — a change of 86.49% (higher).

EBIT

2.23 MCAD

YoY

86.49%

Last updated:

In 2025, NexgenRx's EBIT was 2.23 M CAD, a 86.49% increase from the 1.20 M CAD EBIT recorded in the previous year.

The NexgenRx EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
-557,519.00 CAD
Jan 1, 2019
93,516.00 CAD
Jan 1, 2020
2.16 M CAD
Jan 1, 2021
2.20 M CAD
Jan 1, 2022
287,658.00 CAD
Jan 1, 2023
-143,876.00 CAD
Jan 1, 2024
1.20 M CAD
Jan 1, 2025
2.23 M CAD
The NexgenRx EBIT history
YEAREBITYoY
2.23 MCAD+86.49%
1.20 MCAD-932.18%
-143,876.00CAD-150.02%
287,658.00CAD-86.92%
2.20 MCAD+1.90%
2.16 MCAD+2,207.84%
93,516.00CAD-116.77%
-557,519.00CAD+5.21%
-529,909.00CAD-202.51%
516,911.00CAD-249.05%
-346,804.00CAD-2.91%
-357,183.00CAD-147.28%
755,452.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NexgenRx Revenue

NexgenRx Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
7.17 M CAD
-557,519.00 CAD
-696,862.00 CAD
Jan 1, 2019
9.54 M CAD
93,516.00 CAD
-207,935.00 CAD
Jan 1, 2020
11.04 M CAD
2.16 M CAD
2.12 M CAD
Jan 1, 2021
11.84 M CAD
2.20 M CAD
4.02 M CAD
Jan 1, 2022
12.78 M CAD
287,658.00 CAD
-22,401.00 CAD
Jan 1, 2023
13.85 M CAD
-143,876.00 CAD
-331,970.00 CAD
Jan 1, 2024
16.48 M CAD
1.20 M CAD
614,569.00 CAD
Jan 1, 2025
17.93 M CAD
2.23 M CAD
1.29 M CAD

NexgenRx Margins

NexgenRx stock margins

The NexgenRx margin analysis displays the gross margin, EBIT margin, as well as the profit margin of NexgenRx. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for NexgenRx.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
84.22 %
-7.78 %
-9.72 %
Jan 1, 2019
87.69 %
0.98 %
-2.18 %
Jan 1, 2020
87.54 %
19.55 %
19.16 %
Jan 1, 2021
82.87 %
18.57 %
33.93 %
Jan 1, 2022
79.67 %
2.25 %
-0.18 %
Jan 1, 2023
78.14 %
-1.04 %
-2.40 %
Jan 1, 2024
79.65 %
7.27 %
3.73 %
Jan 1, 2025
83.28 %
12.45 %
7.19 %

NexgenRx Stock analysis

What does NexgenRx do? NexgenRx Inc. is a Canadian company specializing in providing innovative and customer-oriented healthcare solutions. The company was founded in 1999 by Ron Loucks and is headquartered in Ontario. NexgenRx is a leading provider of cloud-based solutions, which help improve the efficiency and quality of healthcare insurance processes. The different business areas of NexgenRx can be divided into three main categories: 1) Health plan administration: NexgenRx serves a wide customer base consisting of companies of all sizes and industries. The company supports employers in offering their employees tailored and cost-effective healthcare benefits. The services include medical and dental care, drug therapies, hospital stays, vision and hearing tests, as well as occupational and disability insurance. 2) eClaims and digital healthcare services: NexgenRx has developed a range of innovative digital healthcare services aimed at making the lives of patients and policyholders easier and more convenient. These include mobile apps for accessing personal health information or an online platform for direct billing. NexgenRx's eClaims solution allows healthcare service providers to directly bill the company, enabling faster processing and less paperwork. 3) Healthcare consulting services: NexgenRx also offers healthcare consulting services. Customers can access the expertise of NexgenRx to assist with healthcare strategy development or the optimization of healthcare plans for their companies. NexgenRx offers a wide range of products and services for its customers, including the Smart Plan, a customizable healthcare program for companies. The company has also developed cloud-based management tools for employers and insurers to effectively manage their healthcare plans. Additionally, NexgenRx provides a modern and simple eClaims system for healthcare service providers, as well as a variety of consulting services aimed at optimizing healthcare plans. In conclusion, NexgenRx Inc. is an innovative company specializing in providing customer-oriented healthcare solutions. The company serves a diverse customer base and offers various products and services, including cloud-based management tools, eClaims systems, and consulting services. Overall, NexgenRx plays a significant role in the healthcare industry by improving the efficiency and quality of insurance processes. NexgenRx is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing NexgenRx's EBIT

NexgenRx's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of NexgenRx's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

NexgenRx's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in NexgenRx’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about NexgenRx stock

EBIT of NexgenRx is 2.23 M CAD in 2025.

EBIT of NexgenRx changed from 1.20 M CAD to 2.23 M CAD, representing a 86.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT NexgenRx since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's NexgenRx historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — NexgenRx

All Key Metrics — NexgenRx